Last week, in my first article, I wrote about novel insights in Cardiology – more precisely about a study on how the combination of 2 lowering therapies (cholesterol and TG) may affect the medical costs in patients with Type 2 Diabetes Mellitus. On this subject, our reader Mr. Rob Padmore sent me an email where he remarked some interesting points of 2 DM. Therefore, I decided to go forward with novel insights in diabetes this week.
